Commander

The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.

Colour video monitors.

The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.

Camera and light source in one compact "Plug-and-Play" device.

Medicine Products:

Sony Flat Panel Displays with C3269 Articulating Arm Sony PVM A3 3-Chip Camera 1CCD ENDOCAM LIGHT 5551

(Date:9/5/2008)...can Humane Shows Public Reluctant to Evacuate, Wit...tion Efforts Confirm S...2007 survey by the American Humane,Association fou...e,assistance if it meant leaving without their fam...moving towards the U.S. coast, residents and,offic...

(Date:9/5/2008)...you need to know what triggers them, experts say ...If you are one of the 36 million Americans who suf...he United States that is free from pollen and othe...lergies don,t only happen in the spring, they can ...l, the most challenging cities to live in are Gree...

(Date:9/5/2008)... /PRNewswire/ -- Arthrosurface, Inc.,( http://www....e joint,resurfacing systems, announced that it has...pivotal investigation for its line of focal knee,r...e no outstanding safety,concerns" with the device ...has been evaluating the safety and efficacy of its...

(Date:9/5/2008)...f Diabetes and Digestive and Kidney Diseases (NIDD...), announces awards to eight academic research cen...chronic pelvic pain disorders by looking for clues...rch investment for the five-year project is estima...this novel research effort is an excellent example...

Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2 Health News:Nearly Half of Americans Won't Flee Without Fido 3 Health News:Nearly Half of Americans Won't Flee Without Fido 4 Health News:No Place Safe From Allergies 2 Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2 Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2 Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3

[0] Nearly Half of Americans Won't Flee Without Fido [0] No Place Safe From Allergies [0] Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage [0] NIH launches unique effort to advance study of urologic chronic pelvic pain disorders

...us teenager who spurns parental guidance in favor ... adolescents who think their parents disapprove of...ns are much less likely to smoke if they think the...rental disapproval works even if the parents are s...

...nd not only on what he or she eats, but also how o...lder adults who ate frequently throughout the day ...th those who tended to down one or two large meals...quent eaters, on average, had a higher calorie and...

... wide range of influenza viruses circulate in wild...n to infect humans. These are two subtypes of the ...first human case of the disease was reported in Ho...f the H5N1 sub-type - went on to kill six people a...

...nts who are depressed are more likely to be re-adm...ression is linked to poor physical health, and thi...r people. Researchers in Switzerland, studied over...for depression and then followed them up for six m...

Other Medicine News:

Teens listen to parents about smoking Eating More Often May Help Lower Cholesterol Birds breed viruses Depression a possible danger in elderly

(Date:9/3/2008)...Focuses Operations, Updates Zingo Launch Progress ...ategy Conference Call Today at 11...- Anesiva,Inc. (Nasdaq: A...cture,operations to focus on commercial and late-s...ion to a specialty pharmaceutical pain management,...

(Date:9/3/2008)...to be Evaluated in Repeat-Dosing Study in Subjects...FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq: ...2 clinical trial (SB-509-801) to evaluate its drug...enerative motor-neuron disease for which there,are...s drug, SB-509, is an injectable formulation of a ...

(Date:9/2/2008)..., Sept. 3 /- Forest Laborat...l, S.A. today announced results from,two global Ph...g-acting,inhaled anticholinergic for the treatment...sease (COPD). In both the ACCLAIM/COPD I&II,(AClid... In Moderate to,Severe COPD Patients) studies, onc...

(Date:9/2/2008)...gates Join World Vision, ONE to Build Hope and Giv...re/ -- Delegates to the,Republican Party Conventio...munities around the world including evacuees in th...nd AIDS in developing countries: "We are here,to h...ting party delegates to do,something unconventiona...

Breaking Medicine Technology:Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4 Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4 Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 2 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 3 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 4 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 5 Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD) 6 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3 Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4 Scientists 3A New technique identifies molecular biomarkers for disease 15546 1 Scientists 3A New technique identifies molecular biomarkers for disease 15546 2 Scientists 3A New technique identifies molecular biomarkers for disease 15546 3 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 1 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 2 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 3 See More Do More 3A Siemens Highlights New Generation of Interventional Imaging Systems for Cardiology at ACC 15541 4 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 1 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 2 Blue Cross Consumer directed Health Plan Options Blue Members Not Sacrificing Health for the Sake of Saving Money 15536 3 ExonHit Appoints a New Management Board 4283 1 ExonHit Appoints a New Management Board 4283 2 ExonHit Appoints a New Management Board 4283 3 ExonHit Appoints a New Management Board 4283 4

[0] Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company [0] Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)[0] Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)[0] Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees

...e Showed Substantial,Reduction of Disease Activity...ple Sclerosis , Combination Treatment With Antibio...erated , KANSAS CITY, Mo, May 4, 2007 - New data f... combination of Copaxone,(glatiramer acetate injec...educed T1 Gadolinium (Gd)-enhancing lesions of the...

...S Pharmaceuticals plc,(LSE: CEN), the Cambridge ba...on of an independent study in the respected scient...onist, CNS 5161. CeNeS,is developing CNS 5161 as a...ependent study builds on the work that CeNeS has,a...ported in ,Synapse, Dr Anat Biegon and her group,...

Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis Independent publication supports the profile of CeNeS phase II,compound, CNS 5161

Products	Commander
Company	Abbott Diagnostics
Item	Commander
Features	Can initiate up to 800 tests per hour Screens blood for hepatitis, retrovirus and other analytes
Description	The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incubator.
Info	Abbott Diagnostics Customer Service: (847) 937-6100 Web site: http://www.abbottdiagnostics.com/